Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Receptor Agonist
100%
A1 Receptor
100%
Glucagon-like
100%
Liraglutide
100%
Heroin
37%
Rapid Eye Movement Sleep
37%
Opioids
25%
Wakefulness
25%
Clinical Application
12%
Drug Use Disorder
12%
Subcutaneous Injection
12%
Dark Period
12%
Sleep Disturbance
12%
Protective Effect
12%
Fentanyl
12%
Within-subject Design
12%
General Health
12%
Obesity Treatment
12%
Nave
12%
Physiological Function
12%
Adult Male Rats
12%
EEG Electrodes
12%
Safety Issues
12%
Active Period
12%
Light-dark Cycle
12%
Animal Bodies
12%
Bout Duration
12%
EMG Electrodes
12%
Immunology and Microbiology
Agonist
100%
REM Sleep
100%
Heroin
100%
Glucagon-Like Peptide-1
100%
Body Weight
33%
Low Drug Dose
33%
Light Dark Cycle
33%
Neuroscience
Glucagon-Like Peptide-1 Agonist
100%
Liraglutide
100%
Heroin
37%
Non-Rapid Eye Movement Sleep
37%
Wakefulness
25%
Electromyography
25%
Sleep Disorder
12%
Duragesic
12%
Fentanyl
12%
Pharmacology, Toxicology and Pharmaceutical Science
Liraglutide
100%
Glucagon Like Peptide 1 Receptor Agonist
100%
Diamorphine
37%
Subcutaneous Injection
12%
Sleep Disorder
12%
Duragesic
12%
Table Salt
12%
Agricultural and Biological Sciences
Liraglutide
100%
Glucagon-Like Peptide 1 Receptor
100%